HHealth Read More Consuming fat before carbohydrates reduces post-meal blood glucoseOctober 8, 2026 In treating diabetes, post-meal elevation of glucose levels is an important therapeutic target. Existing clinical studies indicate that…
HHealth Read More New spin-out launches technology to revolutionize hormone disorder diagnosisSeptember 22, 2026 The University of Birmingham and Imperial College London have announced the launch of Intelligent Mass Spec Solutions Ltd…
HHealth Read More New genetic map helps track aggressive prostate cancer developmentSeptember 9, 2026 Prostate cancer is the second most common form of cancer among men globally. Yet, we still know relatively…
SScience Read More New study uncovers bacterial route to testosterone productionSeptember 5, 2026 Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease…
HHealth Read More HRT linked to lower dementia risk, but timing and menopause type matterAugust 28, 2026 A large UK Biobank analysis reveals how menopause type, estrogen exposure, genetics, and the timing of HRT may…
HHealth Read More Natural hormone activates brain-to-liver signaling pathway to suppress liver inflammationAugust 10, 2026 Researchers at McMaster University have discovered that a naturally occurring hormone best known for suppressing appetite and promoting weight…
HHealth Read More Too little or too much iodine may push immunity off balanceJuly 28, 2026 A cross-species review traces how iodine influences immune defenses and why the boundary between benefit and harm remains…
SScience Read More Scientists discover master molecular switch for ginseng saponin productionJuly 24, 2026 Sanchi ginseng (Panax notoginseng) is a cornerstone of traditional Chinese medicine, prized for its saponins-bioactive compounds with anti-inflammatory,…
HHealth Read More Popular diabetes drugs do not alter the risk of developing a blinding eye conditionJuly 17, 2026 An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) – a type of…
HHealth Read More Physical activity declines after starting GLP-1 obesity treatmentsJune 14, 2026 Adults with obesity losing weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which…
HHealthcare Read More Too Many Men Are Taking Testosterone, Study Suggests: Risk and BenefitsJune 14, 2026 America is reaching peak testosterone. In 2026, interest in the hormone is everywhere, from T-maxxing trends on social…
HHealth Read More Estrogen loss after menopause impacts heart health through gene regulationApril 27, 2026 Virginia Tech scientists at the Fralin Biomedical Research Institute say the increased risk of cardiovascular disease after menopause…